SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001136261-19-000033
Filing Date
2019-02-01
Accepted
2019-02-01 16:56:28
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 s3body.htm S-3 500652
2 OPINION exh5-1.htm EX-5.1 8005
3 CONSENT exh23-1.htm EX-23.1 1344
4 CONSENT exh23-2.htm EX-23.2 1571
5 LOGO image3867.gif GRAPHIC 5790
  Complete submission text file 0001136261-19-000033.txt   520504
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-229490 | Film No.: 19560491
SIC: 2834 Pharmaceutical Preparations